Nouryon

Nouryon (formerly known as AkzoNobel Specialty Chemicals) is a global specialty chemicals leader. Industries worldwide rely on our essential chemistry in the manufacture of everyday products such as paper, plastics, building materials, and personal care items. We have about 10,000 employees and operate in over 80 countries around the world.

Industrial Chemicals is a business unit (BU) of Nouryon. It produces and markets salt and energy, chlor-alkali products and derivatives like monochloroacetic acid (MCA) and metal salts. It is Europe’s largest producer of vacuum salt and a leading supplier of chlorine, caustic lye, hydrochloric acid and MCA. In the integral vacuum salt and chlor-alkali value chain Nouryon is seen by their peers as technology leader and it has the most energy efficient vacuum salt and chlor-alkali plants in the world. It has many (patented) technologies, world class R&D facilities and R&D partnerships with the leading membrane electrolysis companies. The BU Industrial Chemicals employs approximately 1,800 people and has production sites at Rotterdam, Hengelo and Delfzijl in the Netherlands, Ibbenbüren, Frankfurt and Bitterfeld in Germany, Mariager in Denmark, LeMoyne in the USA and Taixing in China. The business is headquartered in Amsterdam, the Netherlands. The BU Industrial Chemicals consists of four sub- business units (sBU). The sBU Chlor-Alkali has a leading position in northwestern Europe for chlorine and caustic lye. Chlorine finds application in EDC/PVC, epoxies, polyurethanes, phosphorus compounds, caustic is used in a large number of processes in the chemical, pulp and paper, textile, food and mineral industries and hydrogen is used in several chemical applications and used as fuel. Nouryon has been involved in the development of Fuel Cells from the beginning of the nighties and since 2007 a 70 KWe demonstration PEM fuel cell plant has been operated successfully.

Country: Netherlands

Visit the website

Share this information via: Share on LinkedInTweet about this on TwitterShare on FacebookEmail this to someonePrint this page